Interventional Cardiology Devices Market: Global Industry Analysis and Forecast (2023-2029)

The Interventional Cardiology Devices Market was valued at US$ 15.74 Bn. in 2022, and it is expected to reach US$ 29.35 Bn. by 2029, exhibiting a CAGR of 9.31 % during the forecast period 2023-2029.

Interventional Cardiology Devices Market Overview:

Global Interventional cardiology devices are mainly used for the treatment of heart diseases. It uses one type of catheter which inserts into the body and for the treatment of cardiovascular diseases. It happens due to hypertension, diabetes and cardiovascular disorder. Interventional Cardiology Devices Market To know about the Research Methodology :- Request Free Sample Report The report explores the Interventional Cardiology Devices Market's segments (on product, End-User, Application, Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2017 to 2020. The report investigates the Interventional Cardiology Devices Market’s drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Interventional Cardiology Devices Market's contemporary competitive scenario.

Interventional Cardiology Devices Market Dynamics:

The geriatric population is rising, the number of patients with cardiovascular and vascular disorders has been steadily growing. This has increased demand for equipment used to treat vascular and cardiovascular illnesses. Additionally, peripheral vascular devices and interventional cardiology can be used to treat a variety of heart and artery conditions.  technological developments have had a favorable impact on the market shares for peripheral vascular and interventional cardiology devices. Additionally, the market growth for peripheral vascular and interventional cardiology devices is positively impacted by the rapidly expanding healthcare sector in developing nations. Another aspect promoting expansion is the creation of novel bioabsorbable and drug-eluting stents, pacemakers, and drug-coated mesh tubes. In accordance with this, the rising use of advanced imaging techniques for the early detection and prompt treatment of cardiovascular diseases, such as intravenous ultrasound (IVUS), fractional flow reserve (FFR), and optical coherence tomography (OCT), is further boosting the market. Other reasons, such as increasing public healthcare spending capacity and significant medical infrastructure improvements, particularly in developing nations, are predicted to fuel market expansion. The market for interventional cardiology devices is benefiting from technological advancement due to the availability of a sophisticated healthcare infrastructure, supportive government initiatives for product development, high patient awareness levels, and relatively high healthcare expenditures. Market companies are competing to introduce cutting-edge products for better treatment, and they have funded R&D projects to enhance their current offerings and introduce new platforms. The most serious behavioral risk factors for heart disease and stroke are eating poorly, smoking, being inactive, and consuming too much alcohol. People may have signs including obesity and excessive blood pressure. As a result, cardiovascular illnesses result from this. During the anticipated term, all of these variables will fuel the market for interventional cardiology devices. Cardiovascular disease is becoming more common as a result of obesity. Additionally, the prevalence of coronary artery diseases has increased due to changing lifestyles marked by smoking, heavy alcohol intake, and inactivity. Cardiologists can carry out the treatments swiftly and without allowing them get problematic with the use of interventional cardiology instruments. The global market for interventional cardiology devices is growing as a result of the increasing need for safe and cutting-edge technology. Frequent technological breakthroughs will enable the creation of minimally invasive coronary stents, high precision, and improved dependability. By raising adoption rates, this could enhance market growth. Furthermore, the market for interventional cardiology devices will expand due to the high number of patients with coronary heart disorders who will have a high demand for coronary intervention procedures. In order to fulfill the increasing demand from patients, the key companies are focusing their efforts and initiatives on the development of minimally invasive coronary stents, which is driving up market demand for interventional cardiology devices. The global market for interventional cardiology devices is expanding due to factors such as the rapidly aging population, improved patient awareness of cardiovascular illnesses, and the growing demand for patient monitoring and treatment. Numerous governmental and non-governmental organizations, educational institutions, and significant market participants have started public awareness campaigns to spread information about illnesses and their treatments, as well as the availability of more sophisticated technologies and procedures at healthcare facilities. The development of more sophisticated and inventive cardiovascular devices as well as the simplicity with which regulatory licenses can be obtained are other factors driving market expansion. The development of the global market for interventional cardiology devices is anticipated to be hampered by complications related to interventional cardiology operations. Complications with interventional cardiology procedures include the development of blood clots around the stent and aberrant arterial narrowing following the repair procedure. some of the stents are metallic, an MRI scan cannot be done. Government laws and strict approval standards may also restrict business expansion. The presence of efficient first-line treatments, high device costs, and strict regulatory requirements can all be seen as obstacles to the expansion of the interventional cardiology devices market. The complex regulatory standards for medical device affiliation are modified to meet evolving needs. The legal considerations involved in these regulations are the main reason why they are difficult. In order to maintain public safety, medical device performance and quality must undergo rigorous scrutiny. Therefore, the demanding and complicated standards used to affiliate medical gadgets limit the global market's expansion to some extent. The advancement of technology in the market is a key factor fueling the opportunities of the interventional cardiology devices market. Transcatheter aortic valve replacement technology is receiving significant investment from the top interventional cardiology device corporations, who are also buying up multiple start-up businesses. The market for interventional cardiology and peripheral vascular devices is anticipated to face challenges from the availability of alternative treatments and a shortage of experienced workers with knowledge of these devices.

COVID-19 Impact on Interventional Cardiology Devices Market:

The new coronavirus has rapidly spread over a number of nations and regions, having a profound effect on both individual lives and the community as a whole. It started off as a human health issue and is now a serious threat to international trade, the economy, and the financial system. Global healthcare spending has increased as a result of the COVID-19 pandemic's heightened emphasis on the value of public healthcare institutions. Additionally, once the COVID-19 vaccine enters the market, fewer cases of COVID-19 are anticipated in the near future. The result has been the full-scale reopening of manufacturing facilities for peripheral vascular devices and interventional cardiology. By the beginning of 2022, this is anticipated to aid in the interventional cardiology market's recovery. Companies that produce interventional cardiology and peripheral vascular devices must concentrate on safeguarding their employees, operations, and supply networks in order to respond to sudden events and implement new working procedures once COVID-19 infection cases start to fall.

Interventional Cardiology Devices Market Segment Analysis:

Based on Type, Catheters Segment is dominating the market with highest CAGR during the forecast period. This is brought on by the high and rising prevalence of coronary artery disorders as well as the growing understanding of the advantages of Coronary artery disorders early diagnosis. Based on End-User, Hospitals segment is dominating the market with highest CAGR during the forecast period. Advanced level of instruments and treatment facility is available with specialized consultants, that’s why this segment dominates the market.

Interventional Cardiology Devices Market Regional Insights:

The North America region dominated the market with xx% share in 2022. The North America region is expected to witness significant growth at a CAGR of xx% through the forecast period. United States can support a high pace of medical device innovation and has a high consumption rate for expensive interventional cardiology devices, it has a sizable global market share for these products. Another important feature that has helped the region's relatively high healthcare spending prospects for a wide range of interventional cardiology equipment. In addition, a few of the major cardiology medical device companies in the area are creating unique products and technologies to compete with already available items, while others are purchasing and collaborating with other businesses that are now hot on the market. Due to changing lifestyle habits like dietary irregularities and rising obesity rates, the UK is predicted to hold the second-largest market share for interventional cardiology devices. These factors, along with a rise in the world's smoker population, are to blame for this rise in the prevalence of cardiovascular disease. The adoption of these items in this area is also reliant on the reimbursement regulations set forth by various European nations. The rising prevalence of cardiovascular diseases in both geriatric and paediatric populations, growing public awareness of the affordability and practicality of cardiology medical devices, and rising healthcare costs are the main drivers of the interventional cardiology devices market growth in China , India, Japan and South Korea. The objective of the report is to present a comprehensive analysis of the Interventional Cardiology Devices Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Interventional Cardiology Devices Market dynamic, structure by analyzing the market segments and projecting the Interventional Cardiology Devices Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, product portfolio, growth strategies, and regional presence in the Interventional Cardiology Devices Market make the report investor’s guide.

Interventional Cardiology Devices Market Scope: Inquire before buying

Global Interventional Cardiology Devices Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 15.74 Bn.
Forecast Period 2023 to 2029 CAGR: 9.31% Market Size in 2029: US $ 29.35 Bn.
Segments Covered: by Product Angioplasty Balloons

Old/Normal Balloons Drug-eluting Balloons Cutting and Scoring Balloons

Angioplasty Stents

Drug-eluting Stents Bare-metal Stents Bioabsorbable Stents

Structural Heart Devices

 Aortic Valve Therapy Devices oOther Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)

Catheters

Angiography Catheters Guiding Catheters IVUS/OCT Catheters

Plaque Modification Devices

Atherectomy Devices Thrombectomy Devices

Hemodynamic Flow Alteration Devices

Embolic Protection Devices Chronic Total Occlusion Devices

Other Devices

Guidewires Vascular Closure Devices Introducer Sheaths Hemostasias Valves Balloon Inflation Devices

by End User Hospitals Ambulatory Surgical Centers Others
by Application Congenital Heart Defect Correction Coronary Thrombectomy Angioplasty Valvuloplasty Percutaneous Valve Repair Other

Interventional Cardiology Devices Market by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest)

Interventional Cardiology Devices Market Key Players

1. Abbott Laboratories 2. B. Braun Melsungen AG 3. Boston Scientific Corporation 4. Becton, Dickinson and Company. 5. Cardinal Health Inc. 6. Cook Group 7. Medtronic plc 8. Terumo Group 9. Koninklijke Philips N.V. 10. Biotronik SE & Co. KG 11. Edward Lifescinces Corporation 12. iVascular 13. Biosensors International Group 14. BIOTRONIK SE & Co. KG 15. ENDOCOR GmbH 16. Medinol Ltd. Frequently Asked Questions: 1] What segments are covered in the Global Market report? Ans. The segments covered in the Market report are based on product, End User, and Application. 2] Which region is expected to hold the highest share in the Market? Ans. North America region is expected to hold the highest share in the Market. 3] What is the market size of the Market by 2029? Ans. The market size of the Market by 2029 is expected to reach US$ 29.35 Bn. 4] What is the forecast period for the Market? Ans. The forecast period for the Market is 2023-2029. 5] What was the market size of the Market in 2022? Ans. The market size of the Market in 2022 was valued at US$ 15.74 Bn.
1. Global Interventional Cardiology Devices Market: Research Methodology 2. Global Interventional Cardiology Devices Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Interventional Cardiology Devices Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Interventional Cardiology Devices Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12 COVID-19 Impact 4. Global Interventional Cardiology Devices Market Segmentation 4.1 Global Interventional Cardiology Devices Market, by Product (2022-2029) • Angioplasty Balloons o Old/Normal Balloons o Drug-eluting Balloons o Cutting and Scoring Balloons • Angioplasty Stents o Drug-eluting Stents o Bare-metal Stents o Bioabsorbable Stents • Structural Heart Devices o Aortic Valve Therapy Devices o Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices) • Catheters o Angiography Catheters o Guiding Catheters o IVUS/OCT Catheters • Plaque Modification Devices o Atherectomy Devices o Thrombectomy Devices • Hemodynamic Flow Alteration Devices o Embolic Protection Devices o Chronic Total Occlusion Devices • Other Devices o Guidewires o Vascular Closure Devices o Introducer Sheaths o Hemostasias Valves o Balloon Inflation Devices 4.2 Global Interventional Cardiology Devices Market, by End User (2022-2029) • Hospitals • Ambulatory Surgical Centers • Others 4.3 Global Interventional Cardiology Devices Market, by Application (2022-2029) • Congenital Heart Defect Correction • Coronary Thrombectomy • Angioplasty • Valvuloplasty • Percutaneous Valve Repair • Other 5. North America Interventional Cardiology Devices Market(2022-2029) 5.1 North America Interventional Cardiology Devices Market, by Product (2022-2029) • Angioplasty Balloons o Old/Normal Balloons o Drug-eluting Balloons o Cutting and Scoring Balloons • Angioplasty Stents o Drug-eluting Stents o Bare-metal Stents o Bioabsorbable Stents • Structural Heart Devices o Aortic Valve Therapy Devices o Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices) • Catheters o Angiography Catheters o Guiding Catheters o IVUS/OCT Catheters • Plaque Modification Devices o Atherectomy Devices o Thrombectomy Devices • Hemodynamic Flow Alteration Devices o Embolic Protection Devices o Chronic Total Occlusion Devices • Other Devices o Guidewires o Vascular Closure Devices o Introducer Sheaths o Hemostasias Valves o Balloon Inflation Devices 5.2 North America Interventional Cardiology Devices Market, by End User (2022-2029) • Hospitals • Ambulatory Surgical Centers • Others 5.3 North America Interventional Cardiology Devices Market, by Application (2022-2029) • Congenital Heart Defect Correction • Coronary Thrombectomy • Angioplasty • Valvuloplasty • Percutaneous Valve Repair • Other 5.4 North America Interventional Cardiology Devices Market, by Country (2022-2029) • United States • Canada • Mexico 6. Europe Interventional Cardiology Devices Market (2022-2029) 6.1. European Interventional Cardiology Devices Market, by Product (2022-2029) 6.2. European Interventional Cardiology Devices Market, by End User (2022-2029) 6.3. European Interventional Cardiology Devices Market, by Application (2022-2029) 6.4. European Interventional Cardiology Devices Market, by Country (2022-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Interventional Cardiology Devices Market (2022-2029) 7.1. Asia Pacific Interventional Cardiology Devices Market, by Product (2022-2029) 7.2. Asia Pacific Interventional Cardiology Devices Market, by End User (2022-2029) 7.3. Asia Pacific Interventional Cardiology Devices Market, by Application (2022-2029) 7.4. Asia Pacific Interventional Cardiology Devices Market, by Country (2022-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Interventional Cardiology Devices Market (2022-2029) 8.1 Middle East and Africa Interventional Cardiology Devices Market, by Product (2022-2029) 8.2. Middle East and Africa Interventional Cardiology Devices Market, by End User (2022-2029) 8.3. Middle East and Africa Interventional Cardiology Devices Market, by Application (2022-2029) 8.4. Middle East and Africa Interventional Cardiology Devices Market, by Country (2022-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Interventional Cardiology Devices Market (2022-2029) 9.1. South America Interventional Cardiology Devices Market, by Product (2022-2029) 9.2. South America Interventional Cardiology Devices Market, by End User (2022-2029) 9.3. South America Interventional Cardiology Devices Market, by Application (2022-2029) 9.4 South America Interventional Cardiology Devices Market, by Country (2022-2029) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1 Abbott Laboratories 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 B. Braun Melsungen AG 10.3 Boston Scientific Corporation 10.4 Becton, Dickinson and Company. 10.5 Cardinal Health Inc. 10.6 Cook Group 10.7 Medtronic plc 10.8 Terumo Group 10.9 Koninklijke Philips N.V. 10.10 Biotronik SE & Co. KG 10.11 Edward Lifescinces Corporation 10.12 iVascular 10.13 Biosensors International Group 10.14 BIOTRONIK SE & Co. KG 10.15 ENDOCOR GmbH 10.16 Medinol Ltd.
  • INQUIRE BEFORE BUYING